Key Development Novartis has announced another workforce reduction, eliminating 322 positions at its East Hanover, New Jersey headquarters, according to... Read more
Tag: #GlobalTrends
09/07/2026
Published by MedBiz
ASTRAZENECA BETS ON CHINA TO STRENGTHEN ITS RESPIRATORY PIPELINE
09/07/2026
Published by MedBiz
Key Development AstraZeneca has committed up to $2.1 billion in a global licensing agreement with China's Sino Biopharmaceutical for TQC3721,... Read more
ASTRAZENECA’S $1.9B CHINA BET: WHY RESPIRATORY INNOVATION IS BECOMING BIG PHARMA’S NEXT BATTLEGROUND
08/07/2026
Published by MedBiz
Key Development AstraZeneca has expanded its strategic partnership with China’s pharmaceutical sector through a licensing agreement with Sino Biopharmaceutical worth... Read more
VERTEX’S $10 BILLION BET ON CRINETICS SIGNALS THE NEXT PHASE OF RARE DISEASE CONSOLIDATION
08/07/2026
Published by MedBiz
Key Development Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in a transaction valued at approximately US$10 billion, marking one... Read more
Europe Moves Bispecific Antibodies Earlier in Follicular Lymphoma Care as AbbVie Secures New Regulatory Milestone
07/07/2026
Published by MedBiz
Key Development The European Commission has approved AbbVie and Genmab's bispecific antibody TEPKINLY (epcoritamab) in combination with lenalidomide and rituximab... Read more





